USS Investment Management Ltd decreased its position in Xylem Inc. (NYSE:XYL – Free Report) by 72.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,933 shares of the industrial products company’s stock after selling 30,909 shares during the quarter. USS Investment Management Ltd’s holdings in Xylem were worth $1,426,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also modified their holdings of the company. Callahan Advisors LLC bought a new stake in Xylem during the fourth quarter valued at about $1,721,000. Northwestern Mutual Wealth Management Co. increased its stake in shares of Xylem by 2,309.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 431,824 shares of the industrial products company’s stock worth $54,314,000 after purchasing an additional 413,904 shares during the period. Abacus Wealth Partners LLC bought a new position in shares of Xylem in the fourth quarter worth about $1,663,000. Boston Common Asset Management LLC boosted its stake in Xylem by 15.3% during the 4th quarter. Boston Common Asset Management LLC now owns 143,740 shares of the industrial products company’s stock valued at $19,575,000 after purchasing an additional 19,073 shares during the period. Finally, Norges Bank acquired a new stake in Xylem in the 4th quarter valued at approximately $361,012,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the sale, the chief accounting officer owned 3,605 shares in the company, valued at $423,443.30. The trade was a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Jerome A. Peribere purchased 1,210 shares of the stock in a transaction on Monday, May 4th. The stock was acquired at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the acquisition, the director directly owned 27,209 shares in the company, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.32% of the stock is owned by insiders.
Xylem Trading Up 0.1%
Xylem (NYSE:XYL – Get Free Report) last announced its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.03. The company had revenue of $2.12 billion for the quarter, compared to analyst estimates of $2.11 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.Xylem’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, equities analysts forecast that Xylem Inc. will post 5.51 EPS for the current year.
Xylem Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were given a $0.43 dividend. This represents a $1.72 annualized dividend and a yield of 1.5%. The ex-dividend date of this dividend was Thursday, May 28th. Xylem’s dividend payout ratio (DPR) is 42.79%.
Wall Street Analyst Weigh In
A number of brokerages have recently commented on XYL. Citigroup cut their price target on Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. Oppenheimer lowered their price objective on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 29th. CLSA raised shares of Xylem to a “hold” rating in a research report on Thursday, June 25th. Stifel Nicolaus cut their target price on shares of Xylem from $163.00 to $159.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Finally, Weiss Ratings downgraded shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, May 8th. Eight equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $153.54.
Check Out Our Latest Analysis on Xylem
Xylem Company Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Featured Stories
- Five stocks we like better than Xylem
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
